Skip to main content
Back
About Us
Our Story
Our Team
Technology + Science
Indications
Publications
Contact
Publications
J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Hepatocellular Carcinoma (HCC)
Learn More
Orphan Drug Designation for Treatment of Autosomal Dominant Polycystic Kidney Disease
Learn More
Autosomal Dominant Polycystic Kidney Disease
Learn More
Progeria
Learn More
FDA Grants J&D Pharmaceuticals Rare Pediatric Disease Designation and Orphan Drug Designation
Learn More
History and Development of the Salicylates
Learn More
Molecular Mechanism of action of JD-004 and JD-005
Learn More
JD-004 improves TBI outcomes in the rodent model
Learn More
PC Reduces NSAID-Induced GI Toxicity
Learn More
The Role of JD-005 in TBI: Targeting Acetylated Tau
Learn More
Interested in learning more?
Contact Us
